Matt focusses on the financial and operational management of the London Stock Exchange-listed International Biotechnology Trust plc, whilst also providing financial and transactional support for the London SV Health Investor teams.
Matt came to SV Health Investor after five years at PwC, where he was responsible for managing a portfolio of audit clients, which predominantly consisted of large, FTSE-listed financial services organizations and small, alternative asset managers. Prior to becoming an accountant, Matt worked as a research scientist for GlaxoSmithKline.
Matt has a MChem & BSc (First Class), Chemistry; Chartered Accountant (ACA).
- +44 (0) 20 7421 7082